Stock listing

FYBD Stock Price, News, Filings & Events — Formycon Ag

Selected listing: FYBD · AQUISEU · EUR · GB

This page tracks Formycon Ag's FYBD:AQUISEU listing on AQUISEU in EUR for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following FYBD:AQUISEU. FYBD:AQUISEU is the stock-level entry point for investors researching Formycon Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Formycon AG is a publicly traded company based in Germany, with a market capitalization of approximately €383.79 million. The company focuses on the development of biosimilars and biopharmaceuticals, aiming to provide affordable treatment options in the healthcare sector. Formycon is committed to advancing its innovative product pipeline to meet the needs of patients and healthcare providers.

FYBD:AQUISEUEURGBUpdated September 11, 2026
Formycon Ag logo
Ticker
FYBD:AQUISEU
Asset type
Stock
Market cap
$422.6M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
AQUISEU
Currency
EUR

Formycon Ag FYBD:AQUISEU stock context

This page tracks Formycon Ag's FYBD:AQUISEU listing on AQUISEU in EUR for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following FYBD:AQUISEU. FYBD:AQUISEU is the stock-level entry point for investors researching Formycon Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Formycon AG is a publicly traded company based in Germany, with a market capitalization of approximately €383.79 million. The company focuses on the development of biosimilars and biopharmaceuticals, aiming to provide affordable treatment options in the healthcare sector. Formycon is committed to advancing its innovative product pipeline to meet the needs of patients and healthcare providers.

Latest news from Formycon Ag

All Formycon Ag news →

Research Formycon Ag

Alternate listings